TAMARA UNDERWOOD: Open Payments
NPI 1508631722 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 36 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $802
Food & beverage: $757Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $153 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Novo Nordisk Inc | 7 | $124 |
| ABBVIE INC. | 5 | $109 |
| PFIZER INC. | 3 | $51 |
| Exact Sciences Corporation | 3 | $50 |
| Astellas Pharma US Inc | 2 | $47 |
| Abbott Laboratories | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $24 |
| Corcept Therapeutics | 1 | $21 |
Products named: AIRSUPRA, MOUNJARO, Ozempic, UBRELVY, Cologuard Collection Kit, QULIPTA, Veozah, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
